Prior observation has indicated that Frizzled 2 (FZD2)-induced epithelial-mesenchymal transition (EMT) could be a key step in metastasis and early recurrence of hepatocellular carcinoma (HCC). However, the mechanism underlying tumor development and progression due to aberrant FZD2 expression is poorly defined. Here, we provide evidence that FZD2 is a driver for EMT, cancer stem cell properties, and vasculogenic mimicry (VM) in HCC. We found that FZD2 was highly expressed in two cohorts of 
| INTRODUC TI ON
Hepatocellular carcinoma represents the sixth most common malignancy in the world and the third leading cause of cancer-related deaths worldwide, with particularly high morbidity in China due to the high incidence of HBV infection. 1 Although HCC is curable if detected early, most patients are diagnosed in the advanced stage and have an unfavorable outcome. 2 Tumor metastasis and recurrence are the principal causes accounting for poor outcomes. 3 The clinical stage, based on the Barcelona Clinic Liver Cancer and TNM classification systems, is currently the most common prognostic factor at the time of diagnosis, but the molecular mechanism involved in HCC progression and metastasis is still unclear. 4 Thus, novel prognostic biomarkers and promising therapeutic targets that are associated with HCC progression and metastasis would be of great clinical significance.
Wnt proteins are a family of transcriptional genes that play pivotal roles in cell survival, migration, and invasion by coordinating with one or more of the FZD receptors. 5 Multiple studies have reported that the canonical Wnt/β-catenin signaling pathway is activated during EMT. [6] [7] [8] Among them, a study has revealed that FZD2 drives EMT and cell metastasis through a previously unrecognized, noncanonical pathway that involves molecules such as the tyrosine kinase (FYN) and STAT3. 9 Another study confirmed that FZD2 upregulation was significantly correlated with EMT status in HCC. 10 Epithelial-mesenchymal transition has been associated with CSC properties and VM in several tumors. [11] [12] [13] Cancer stem cells are a small subgroup within tumors that are capable of selfrenewal and maintain tumor-initiating capacity through differentiation into the heterogeneous nature of tumor cells that comprise the primary tumor. They also provide the possibility for cells that cause tumor recurrence and drug resistance. Increasing evidence indicates that VM, the formation of a vascular-like structure that mimics the embryonic vascular network pattern to support tumor tissue, is a critical step in tumor progression, invasion, and metastasis. Since the discovery of VM, research has been carried out on the molecular mechanism by which VM formation emerges, in an effort to identify valuable therapeutic targets. The noncanonical Wnt signaling pathway, which provides important clues to tumorigenesis, is implicated in both VM and CSCs, [14] [15] [16] and thus is of great concern. In this study, we found that FZD2 might be implicated in EMT-mediated metastasis and CSC maintenance, as well as VM through interacting with Hippo signaling, in HCC. Our study provides a plausible mechanism for HCC metastasis and early recurrence.
| MATERIAL S AND ME THODS

| Patients and tissue samples
Two independent cohorts, each consisting of 100 HCC patients with HCC, were enrolled in this study. 
| Cell lines
Hepatocellular carcinoma cell lines SNU387, SNU449, and HepG2
were obtained from the ATCC (Manassas, VA, USA). The cells were cultured in RPMI-1640 (SNU387 and SNU449) or DMEM (HepG2) (Corning, Logan, UT, USA) supplemented with 10% FBS (Corning) at 37°C in a humidified 5% CO 2 incubator.
| Animals
Male BALB/c-nude mice (4-6 weeks old) were obtained from the 
| Quantitative RT-PCR analysis
Total RNA was extracted using the RNAiso reagent (TaKaRa, Dalian, China). Quantitative PCR was carried out using the SYBR Premix Ex
Taq kit (TaKaRa) following the manufacturer's instructions. Results were normalized to the expression levels of GAPDH. Primers sequences were as follows: FZD2 forward primer, 5′-TCC TCA AGG   TGC CAT CCT ATC TC -3′ and reverse primer, 5′-TGG TGA CAG TGA   AGA AGG TGG AAG-3′; and GAPDH forward primer, 5′-CAG GAG   GCA TTG CTG ATG AT-3′ and reverse primer, 5′-GAA GGC TGG GGC TCA TTT-3′. The qRT-PCR assay results were analyzed by the 2 −ΔΔCT method. 
| Immunohistochemistry staining
Immunohistochemistry staining was undertaken as described in our previous report. 18 The expression of FZD2 was examined by light microscopy by evaluating 1000 cells in 5 fields to obtain the percentage of positive cells, which was multiplied by staining intensity to produce a weighted score for each case. Cases with a weighted score of 0-3 were regarded negative and those with a score of 4-8 positive.
Primary Abs are listed in Table S1 .
| CD34/PAS double staining
To display the VM structures in HCC human samples and mouse xenografts, histological sections were IHC stained for CD34, then stained with PAS (cat. BA4080A; BASO, Zhuhai, China) following the manufacturer's instructions. 
| Small interfering RNA transient transfection
| Lentiviral construction and cell transfection
The U6-sh-FZD2-UFC1-CMV-GFP lentiviral vector was pur- 
| Cell viability assay
| Flow cytometric analysis
| Migration and invasion assays
| Western blot analysis
Cells were lysed with RIPA buffer (Beyotime, Jiangsu, China) containing 1 mM PMSF. Equivalent total protein (30 μg) was separated by 10% SDS-PAGE. The separated proteins were transferred to a PVDF membrane. The membrane was trimmed and blocked with 5% BSA for 1 hour, and probed with primary Abs (Table S1) Hangzhou, China) was used. Histone H3 was used as a loading control for nuclear protein.
| Three-dimensional tube formation assay
A 3D culture was used to assess the ability of tumor cells to form a VM structure. Cells (2 × 10 4 ) were resuspended in a 200-μL mixture of equal volumes of serum-free DMEM or RPMI-1640 medium, and then placed into 60% Matrigel-coated 96-well plates. After incubation for 4 hours at 37°C, the branch points of the formed tubes, which represented the degree of VM formation, were quantitated under an inverted microscope. 
| Tumorigenicity assay
| RNA sequencing analysis
Total RNA for RNA-Seq was isolated from SNU449 cells infected with either of the lentiviral vectors encoding specific shRNA sequences or the NC vector. Total RNA was quantified and integrity was measured on a BioAnalyzer 2100 (Agilent, Santa Clara, CA, USA). Oligo(dT) magnetic beads were used to select mRNA with polyA tail and the target RNA was obtained after purification. The RNA was fragmented and reverse-transcribed into double-stranded cDNA using N6 random primer. The double-stranded cRNA was processed for end repair and was then ligated with adaptor and amplified by PCR. The PCR products were denatured by heating and the single-stranded cDNA was cyclized using splint oligo and DNA ligase.
The cDNA library was sequenced by BGISEQ-500 (BGI, Shenzhen, China). After primary sequencing data passed quality control, the raw reads were filtered to obtain clean reads, which were aligned to the reference genome using HISAT and to reference gene sequences using Bowtie2. Gene expression was quantified by RSEM.
Differentially expressed genes between FZD2 shRNA-transfected versus control cells were screened using the Poisson distribution method. We used FDR ≤ .001 and |Log 2 Ratio| ≥1 as thresholds to judge the significance of gene expression difference. Differentially expressed genes were subjected to Kyoto Encyclopedia of Genes and
Genomes pathway enrichment analysis.
| Statistical analysis
All experiments were carried out in triplicate and data are presented as the mean ± standard deviation. Means were compared by Student's t test or one-way ANOVA with either SPSS 19.0 software (SPSS, Chicago, IL, USA) or GraphPad Prism 5 (GraphPad Software, La Jolla, CA, USA). Survival curves were calculated using the Kaplan-Meier method. Differences were considered statistically significant when P < .05.
| RE SULTS
| Upregulation of FZD2 in HCC tissues predicts tumor progression and poor survival
We evaluated FZD2 expression in HCC tissues from 2 cohorts of patients with HCC. In cohort 1, we analyzed FZD2 expression by
is overexpressed in hepatocellular carcinoma (HCC) tissues and predicts poor survival for patients with HCC. A, FZD2 mRNA expression was analyzed by quantitative RT-PCR in HCC tissues and adjacent nontumor tissues (cohort 1, n = 100). *P < .05. B, FZD2 was upregulated in 61/100 (61%) of HCC cases. Data are presented as the log 2 ratio of the FZD2 mRNA level in HCC tissues versus that in adjacent nontumorous tissues. C, FZD2 protein expression was detected by immunohistochemical staining (cohort 2, n = 100). D, Representative images of immunohistochemical staining for FZD2 in HCC tissues. E,F, Kaplan-Meier analysis of relapse-free survival in HCC patients from cohort 1 (P = .0007) and cohort 2 (P = .0137). Differences were assessed by log-rank test. G,H, Kaplan-Meier analysis of overall survival in HCC patients from cohort 1 (P = .0365) and cohort 2 (P = .0209). Differences were assessed by log-rank test. **P < .01 We then analyzed the association between FZD2 and clinicopathologic parameters in HCC patients. Statistical analysis indicated a strong correlation between FZD2 expression and tumor size (P = .028 and P = .010, in cohorts 1 and 2, respectively), differentiation (P = .013 and P = .005), portal vein tumor thrombus (P = .046 and P = .000), microvascular invasion (P = .006 and .010), TNM stage (P = .045 and P = .031), Barcelona Clinic Liver Cancer stage (P = .032 and P = .005), metastasis (P = .028 and P = .001), and early recurrence (P = .003 and P = .009) ( Tables 1 and 2 ). Kaplan-Meier analysis suggested a positive correlation between cancerous FZD2 expression and significantly reduced relapsefree survival and overall survival (all P < .05; Figure 1E -H).
| Frizzled 2 promotes cell proliferation, inhibits cell apoptosis, and enhances cell migration and invasion in HCC
We 
| Frizzled 2 drives EMT in HCC
Epithelial-mesenchymal transition plays a vital role in cancer metastasis and progression. The loss of E-cadherin expression and the gain of N-cadherin and Vimentin expression represents the molecular event of EMT. Therefore, we determined the levels of these EMT markers in FZD2-knockdown and -overexpressing cells.
Knockdown of FZD2 induced expression of E-cadherin and suppressed that of N-cadherin, Vimentin, Snail, and Slug, whereas overexpression of FZD2 attenuated E-cadherin expression and promoted N-cadherin, vimentin, Snail, and Slug expression ( Figure 4A ). 
| Frizzled 2 increases stem-like properties of HCC
The recent discovery that CSCs emerge, in part, as a result of EMT has provided a new understanding of the regulatory mechanisms in CSCs. 19 To identify the stemness phenotype, we assessed the expression of the CSC-specific surface marker CD44. Figure 4C ). The effect of FZD2 on Nanog and SOX2 expression was further supported by IHC staining in xenograft tumor tissues ( Figure S1 ).
These findings supported that FZD2 regulated the CSCs feature of HCC cells.
| Frizzled 2 promotes VM formation of HCC cells
With the increasing knowledge about CSC phenotypes and functions, the CSCs concept has been applied to VM, which has also been recently observed in HCC. 20 To elucidate the effect of FZD2 on VM, we evaluated the relationship between FZD2 expression and VM structures in clinical samples. Vasculogenic mimicry structures were visualized by CD34/PAS double staining and were identified as vascular-like channels that were lined by tumor cells, displayed positive staining for PAS but negative staining for CD34 (PAS + CD34 − ), and possibly contained erythrocytes ( Figure 5A ). The presence of a VM structure in an HCC section was designated as VM+, and cases without a VM structure in a whole HCC section were considered VM− cases.
There were more VM+ cases in the FZD2 + group than in the FZD2 − group (P < .01; Figure 5B ). These data suggested a positive correlation between FZD2 and VM in clinical specimens.
To gain further insight into the correlation between FZD2 expression and VM, a 3D tube formation assay was carried out.
As shown in Figure 5C , both SNU387 and SNU449 cells could Collectively, the in vitro and in vivo data indicated that FZD2
promotes VM of HCC cells.
| Frizzled 2 is a regulator of HCC cell invasion and metastasis by activating the Hippo-YAP pathway
To determine the gene networks underlying the biological consequences of FZD2 knockdown, RNA-Seq analysis was carried out. In YAP activity and TAZ levels were evaluated. Yes-associated protein activity is determined by its phosphorylation status and cellular localization. Following phosphorylation, YAP is translocated from the nucleus to the cytoplasm for proteasome-mediated degradation. 19, 20 We also measured the cytosolic kinases upstream of YAP including LATS1, which phosphorylates and inhibits YAP, and MST1/2, which phosphorylates and activates LATS1, and the phosphorylation level ( Figure 6D ). The expression levels of total YAP and TAZ were consistent with the level of nuclear YAP ( Figure 6C ). These data indicated that the tumorigenic effects of FZD2 in HCC might depend on the activity of YAP involved in the Hippo signaling pathway.
| D ISCUSS I ON
In a previous study, Gujral et al 9 Recent studies show that EMT can confer tumor cells with stem cell-like characteristics. 21, 22 In prostate cancer, recent evidence suggested that transforming growth factor-β-induced EMT was mechanistically linked to the formation of highly tumorigenic prostate cancer stem cells with a mesenchymal phenotype, and involved in the upregulation of Snail and Nanog. 23 Enhanced self-renewal, 27 In the statistical analysis we found that increased FZD2 expression was frequently ob- for inhibiting this pathway for therapeutic benefit. However, additional studies are needed to confirm our hypothesis.
Taken together, our current study deepens our understanding of FZD2. First, FZD2 was found to be aberrantly upregulated in Chinese HCC patients with HBV infection. Second, by identifying numerous FZD2-regulated pathways and novel downstream targets, combined with functional studies, we robustly defined the oncogenic role of FZD2 in HCC. Third, we report for the first time that FZD2-induced EMT might promote VM and CSCs, and subsequently contribute to the progress and recurrence of HCC. Finally, this study revealed a promising correlation between the Hippo pathway and FZD2, thus establishing an extensive basis and providing a rationale for studying the role of FZD2 in HCC tumorigenesis.
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